SWK (SWKH) Expected to Announce Quarterly Earnings on Monday

SWK (NASDAQ:SWKH) is projected to announce its Q4 2025 resultson Monday, April 6th. Analysts expect the company to announce earnings of $0.5250 per share for the quarter. Parties can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, March 26, 2026 at 10:00 AM ET.

SWK Price Performance

SWKH opened at $17.10 on Monday. The company has a market capitalization of $206.91 million, a P/E ratio of 9.19 and a beta of 0.30. The company has a debt-to-equity ratio of 0.14, a current ratio of 9.41 and a quick ratio of 9.41. The firm’s fifty day moving average price is $17.01 and its two-hundred day moving average price is $16.57. SWK has a fifty-two week low of $13.17 and a fifty-two week high of $20.49.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “hold (c)” rating on shares of SWK in a report on Monday, December 29th. Two analysts have rated the stock with a Hold rating, According to MarketBeat, SWK currently has an average rating of “Hold” and an average target price of $18.00.

Hedge Funds Weigh In On SWK

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Raymond James Financial Inc. grew its position in SWK by 297.5% in the second quarter. Raymond James Financial Inc. now owns 74,657 shares of the company’s stock valued at $1,100,000 after acquiring an additional 55,874 shares during the period. Russell Investments Group Ltd. lifted its holdings in shares of SWK by 41.2% during the third quarter. Russell Investments Group Ltd. now owns 3,795 shares of the company’s stock valued at $55,000 after acquiring an additional 1,108 shares during the period. Bank of America Corp DE boosted its stake in shares of SWK by 41.8% in the 2nd quarter. Bank of America Corp DE now owns 5,595 shares of the company’s stock valued at $82,000 after purchasing an additional 1,649 shares in the last quarter. NewEdge Advisors LLC boosted its stake in shares of SWK by 5,440.8% in the 3rd quarter. NewEdge Advisors LLC now owns 17,509 shares of the company’s stock valued at $255,000 after purchasing an additional 17,193 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its holdings in shares of SWK by 142.2% in the 4th quarter. Goldman Sachs Group Inc. now owns 38,400 shares of the company’s stock worth $660,000 after purchasing an additional 22,546 shares during the last quarter. Institutional investors own 99.27% of the company’s stock.

SWK Company Profile

SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. This segment also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance.